Syntaxin 3, a member of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein family, is primarily involved in vesicle fusion processes within the cell, particularly in intracellular membrane trafficking and exocytosis. Specifically, Syntaxin 3 plays a crucial role in mediating the fusion of vesicles containing cargo molecules with the target membrane, facilitating the release of contents into the extracellular space or specific organelles. This protein is especially prevalent in epithelial cells, where it regulates the delivery of membrane-bound proteins to the apical plasma membrane, thus influencing various physiological processes such as secretion and absorption in epithelial tissues.
Inhibition of Syntaxin 3 function disrupts intracellular membrane trafficking and exocytosis processes, leading to impairment in vesicle fusion and cargo release. Mechanistically, inhibition may occur through various means, including interference with protein-protein interactions essential for SNARE complex formation, alteration of membrane lipid composition crucial for vesicle docking and fusion, or disruption of regulatory factors involved in Syntaxin 3 activation or function. Additionally, inhibition of Syntaxin 3 may lead to dysregulation of apical membrane protein targeting in epithelial cells, affecting critical cellular functions such as nutrient absorption, ion transport, and secretion. Overall, inhibition of Syntaxin 3 represents a potential avenue for modulating intracellular vesicle trafficking and exocytosis processes, with implications for various physiological and pathological conditions involving disrupted cellular secretion mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A can disrupt the Golgi apparatus and inhibits protein transport, thus indirectly affecting Syntaxin 3. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts intracellular transport, potentially affecting Syntaxin 3 functionality. | ||||||
Dolastatin 10 | 110417-88-4 | sc-507413 | 5 mg | $980.00 | ||
Dolastatin 10 disrupts microtubule dynamics, which can indirectly impact Syntaxin 3. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole can disrupt the microtubule network, which can indirectly influence Syntaxin 3. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A can disrupt actin filaments, which can indirectly affect Syntaxin 3. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D can disrupt actin network, indirectly affecting Syntaxin 3. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90 and disrupts its function, which can indirectly affect Syntaxin 3. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which can indirectly affect Syntaxin 3. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin increases cytosolic calcium levels, indirectly affecting Syntaxin 3. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxyglucose inhibits glycolysis, which can indirectly Influence Syntaxin 3. | ||||||